Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Capitalize on the Therapeutic Drug Monitoring Shift: Benchmark Roche, Abbott, Siemens Healthineers, Thermo Fisher and Bio-Rad to Accelerate Revenue and Defend Market Share

globenewswire.com
ABT Abbott is benchmarked in a report discussing the Therapeutic Drug Monitoring market, which is projected to grow significantly. The article does not provide specific sentiment towards Abbott's performance or prospects within this market. TMO Thermo Fisher Scientific is benchmarked in a report discussing the Therapeutic Drug Monitoring market, which is projected to grow significantly. The article does not provide specific sentiment towards Thermo Fisher Scientific's performance or prospects within this market. BIO Bio-Rad Laboratories is benchmarked in a report discussing the Therapeutic Drug Monitoring market, which is projected to grow significantly. The article does not provide specific sentiment towards Bio-Rad Laboratories' performance or prospects within this market.

Capitalize on the Therapeutic Drug Monitoring Shift: Benchmark Roche, Abbott, Siemens Healthineers, Thermo Fisher and Bio-Rad to Accelerate Revenue and Defend Market Share Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Therapeutic Drug Monitoring - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.

The global market for Therapeutic Drug Monitoring was estimated at US$1.5 Billion in 2025 and is projected to reach US$2.6 Billion by 2032, growing at a CAGR of 8.3% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

What Factors Are Driving the Growth in the Therapeutic Drug Monitoring Market?

The growth in the Therapeutic Drug Monitoring market is driven by several factors, including the rising adoption of personalized medicine, increasing incidence of chronic diseases, and advancements in diagnostic technologies. Innovations like automated analyzers, point-of-care devices, and AI-based software have expanded TDM applications in hospitals and home healthcare settings. The focus on improving patient safety, ensuring accurate dosing, and reducing healthcare costs has further fueled demand, as TDM plays a critical role in optimizing drug therapy. Additionally, expanding healthcare infrastructure, growing pharmacogenomics research, and regulatory support for precision medicine have contributed to the market's growth. As personalized medicine continues to gain traction, TDM is expected to become increasingly integral to individualized patient care.

Report Scope

The report analyzes the Therapeutic Drug Monitoring market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:

Key Insights:

Why You Should Buy This Report:

Key Questions Answered:

Report Features:

Domain Expert Insights

This market report incorporates insights from domain experts across enterprise, industry, academia, and government sectors. These insights are consolidated from multilingual multimedia sources, including text, voice, and image-based content, to provide comprehensive market intelligence and strategic perspectives. As part of this research study, the publisher tracks and analyzes insights from 744 domain experts. Clients may request access to the network of experts monitored for this report, along with the online expert insights tracker.

Key Attributes:

A selection of companies mentioned in this report includes, but is not limited to:

For more information about this report visit https://www.researchandmarkets.com/r/ba314n

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.